Mei‐Hui Hsu

2.3k total citations
33 papers, 1.8k citations indexed

About

Mei‐Hui Hsu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Mei‐Hui Hsu has authored 33 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Pharmacology and 13 papers in Oncology. Recurrent topics in Mei‐Hui Hsu's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Mei‐Hui Hsu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (9 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). Mei‐Hui Hsu collaborates with scholars based in United States, Taiwan and United Kingdom. Mei‐Hui Hsu's co-authors include Eric F. Johnson, Keith J. Griffin, Üzen Savas, C.D. Stout, A. Scott Muerhoff, L. Ashley Cowart, John R. Falck, Jorge H. Capdevila, Shouzuo Wei and Wan‐Ping Hu and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Journal of Medicinal Chemistry.

In The Last Decade

Mei‐Hui Hsu

32 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mei‐Hui Hsu United States 24 1.0k 679 435 349 254 33 1.8k
Üzen Savas United States 24 767 0.7× 940 1.4× 284 0.7× 403 1.2× 144 0.6× 25 1.9k
Dylan P. Hartley United States 24 708 0.7× 576 0.8× 159 0.4× 972 2.8× 123 0.5× 41 2.2k
Miki Shimada Japan 28 703 0.7× 961 1.4× 140 0.3× 616 1.8× 191 0.8× 83 2.0k
Fred K. Friedman United States 27 1.3k 1.3× 979 1.4× 149 0.3× 744 2.1× 119 0.5× 121 2.5k
Richard T. Okita United States 23 586 0.6× 576 0.8× 435 1.0× 213 0.6× 165 0.6× 51 1.5k
Rikiya Ohashi Japan 21 1.1k 1.1× 243 0.4× 572 1.3× 933 2.7× 341 1.3× 48 2.7k
Linda M. Reik United States 22 845 0.8× 1.5k 2.2× 301 0.7× 614 1.8× 102 0.4× 28 2.6k
Sang S. Park United States 24 608 0.6× 1.3k 1.9× 264 0.6× 458 1.3× 88 0.3× 49 2.1k
P. Bentley Switzerland 28 1.1k 1.1× 838 1.2× 615 1.4× 279 0.8× 112 0.4× 75 2.4k
Masayuki Komori Japan 24 732 0.7× 952 1.4× 148 0.3× 424 1.2× 49 0.2× 70 1.7k

Countries citing papers authored by Mei‐Hui Hsu

Since Specialization
Citations

This map shows the geographic impact of Mei‐Hui Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Hui Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Hui Hsu more than expected).

Fields of papers citing papers by Mei‐Hui Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei‐Hui Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Hui Hsu. The network helps show where Mei‐Hui Hsu may publish in the future.

Co-authorship network of co-authors of Mei‐Hui Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Mei‐Hui Hsu. A scholar is included among the top collaborators of Mei‐Hui Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei‐Hui Hsu. Mei‐Hui Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hung, Chia‐Yen, Mei‐Hui Hsu, Shu‐Hui Lee, et al.. (2024). Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT. Journal of the Formosan Medical Association. 123(9). 1010–1017. 2 indexed citations
3.
Hsu, Mei‐Hui & Eric F. Johnson. (2023). Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4. Drug Metabolism and Disposition. 51(12). 1642–1650. 1 indexed citations
4.
Hsu, Mei‐Hui & Eric F. Johnson. (2022). Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5. Journal of Biological Chemistry. 298(5). 101909–101909. 8 indexed citations
5.
Hsu, Mei‐Hui & Eric F. Johnson. (2019). Active-site differences between substrate-free and ritonavir-bound cytochrome P450 (CYP) 3A5 reveal plasticity differences between CYP3A5 and CYP3A4. Journal of Biological Chemistry. 294(20). 8015–8022. 34 indexed citations
6.
Hsu, Mei‐Hui, et al.. (2018). Noncovalent interactions dominate dynamic heme distortion in cytochrome P450 4B1. Journal of Biological Chemistry. 293(29). 11433–11446. 19 indexed citations
7.
Hsu, Mei‐Hui, Üzen Savas, & Eric F. Johnson. (2017). The X-Ray Crystal Structure of the Human Mono-Oxygenase Cytochrome P450 3A5-Ritonavir Complex Reveals Active Site Differences between P450s 3A4 and 3A5. Molecular Pharmacology. 93(1). 14–24. 36 indexed citations
8.
Lee, Pauline, Mei‐Hui Hsu, Jennifer V. Welser-Alves, & Hongfan Peng. (2012). Severe microcytic anemia but increased erythropoiesis in mice lacking Hfe or Tfr2 and Tmprss6. Blood Cells Molecules and Diseases. 48(3). 173–178. 25 indexed citations
9.
Hsu, Mei‐Hui, Üzen Savas, Jerome M. Lasker, & Eric F. Johnson. (2011). Genistein, Resveratrol, and 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside Induce Cytochrome P450 4F2 Expression through an AMP-Activated Protein Kinase-Dependent Pathway. Journal of Pharmacology and Experimental Therapeutics. 337(1). 125–136. 39 indexed citations
10.
Savas, Üzen, Mei‐Hui Hsu, Pryce Gaynor, et al.. (2009). Opposing Roles of Peroxisome Proliferator-activated Receptor α and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model. Journal of Biological Chemistry. 284(24). 16541–16552. 23 indexed citations
11.
Hsu, Mei‐Hui, Üzen Savas, Keith J. Griffin, & Eric F. Johnson. (2007). Human Cytochrome P450 Family 4 Enzymes: Function, Genetic Variation and Regulation. Drug Metabolism Reviews. 39(2-3). 515–538. 111 indexed citations
12.
Sansen, Stefaan, Mei‐Hui Hsu, C.D. Stout, & Eric F. Johnson. (2007). Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. Archives of Biochemistry and Biophysics. 464(2). 197–206. 37 indexed citations
13.
Hsu, Mei‐Hui, et al.. (2006). Regulation of Human Cytochrome P450 4F2 Expression by Sterol Regulatory Element-binding Protein and Lovastatin. Journal of Biological Chemistry. 282(8). 5225–5236. 43 indexed citations
14.
Wang, Jeh‐Jeng, et al.. (2006). Design, Synthesis, and Biological Evaluation of Pyrrolo[2,1-c][1,4]benzodiazepine and Indole Conjugates as Anticancer Agents. Journal of Medicinal Chemistry. 49(4). 1442–1449. 66 indexed citations
15.
Savas, Üzen, Mei‐Hui Hsu, Keith J. Griffin, David Bell, & Eric F. Johnson. (2005). Conditional regulation of the human CYP4X1 and CYP4Z1 genes. Archives of Biochemistry and Biophysics. 436(2). 377–385. 39 indexed citations
16.
Cowart, L. Ashley, Shouzuo Wei, Mei‐Hui Hsu, et al.. (2002). The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands. Journal of Biological Chemistry. 277(38). 35105–35112. 161 indexed citations
17.
Johnson, Eric F., Mei‐Hui Hsu, Üzen Savas, & Keith J. Griffin. (2002). Regulation of P450 4A expression by peroxisome proliferator activated receptors. Toxicology. 181-182. 203–206. 59 indexed citations
18.
19.
Brierley, Catherine H., Sahidan Senafi, Douglas J. Clarke, et al.. (1996). Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Advances in Enzyme Regulation. 36. 85–97. 32 indexed citations
20.
Richardson, Toby H., Mei‐Hui Hsu, Thomas Kronbach, et al.. (1993). Purification and Characterization of Recombinant-Expressed Cytochrome P450 2C3 from Escherichia coli: 2C3 Encodes the 6β-Hydroxylase Deficient Form of P450-3b. Archives of Biochemistry and Biophysics. 300(1). 510–516. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Üzen Savas Breakdown of academic impact, for papers by Dylan P. Hartley Breakdown of academic impact, for papers by Miki Shimada Breakdown of academic impact, for papers by Fred K. Friedman Breakdown of academic impact, for papers by Richard T. Okita Breakdown of academic impact, for papers by Rikiya Ohashi Breakdown of academic impact, for papers by Linda M. Reik Breakdown of academic impact, for papers by Sang S. Park Breakdown of academic impact, for papers by P. Bentley Breakdown of academic impact, for papers by Masayuki Komori
Rankless by CCL
2026